• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy.

作者信息

Joss E, Zuppinger K, Schwarz H P, Roten H

出版信息

Pediatr Res. 1983 Aug;17(8):676-9. doi: 10.1203/00006450-198308000-00015.

DOI:10.1203/00006450-198308000-00015
PMID:6889010
Abstract
摘要

相似文献

1
Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy.垂体性生长衰竭患者的最终身高及长期激素治疗后生长变量的变化
Pediatr Res. 1983 Aug;17(8):676-9. doi: 10.1203/00006450-198308000-00015.
2
The results of long-term growth hormone replacement therapy in Turkish children with growth hormone deficiency.土耳其生长激素缺乏症儿童长期生长激素替代疗法的结果
Turk J Pediatr. 1998 Jan-Mar;40(1):55-60.
3
Response of growth-retarded patients with Hand--Schüller--Christian disease to growth hormone therapy.
N Engl J Med. 1975 Feb 13;292(7):332-3. doi: 10.1056/NEJM197502132920703.
4
[Final height in Turner syndrome treated with growth hormone].[生长激素治疗特纳综合征后的最终身高]
Arch Pediatr. 1994 Apr;1(4):359-62.
5
[Long-term treatment of hypophyseal growth disorders with human growth hormone; results in 38 Dutch children].
Ned Tijdschr Geneeskd. 1979 Mar 31;123(13):510-20.
6
Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.加拿大医学研究委员会人类生长激素治疗试验：治疗的前五年
Can Med Assoc J. 1975 Jun 7;112(11):1301-9.
7
[Statural growth in growth hormone treatment during puberty in irradiated children, from the data of France Hypophyse].
Arch Pediatr. 1994 Apr;1(4):356-8.
8
Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.重组生长激素对多次输血的重型地中海贫血生长发育迟缓患者的短期治疗
J Pediatr Endocrinol Metab. 1998;11 Suppl 3:845-9.
9
Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.长期生长激素治疗对伴有和不伴有典型生长激素缺乏症男孩骨龄和青春期成熟的影响。
J Pediatr. 1994 Aug;125(2):189-95.
10
Final height outcome of growth hormone-deficient patients treated since less than five years of age.五岁前开始治疗的生长激素缺乏症患者的最终身高结果
Acta Paediatr. 1996 Oct;85(10):1167-71.

引用本文的文献

1
Suicides in National Hormone Pituitary Program Recipients of Cadaver-Derived Human Growth Hormone.国家垂体激素项目中接受尸体来源人生长激素治疗者的自杀情况。
J Endocr Soc. 2023 Oct 31;7(12):bvad130. doi: 10.1210/jendso/bvad130. eCollection 2023 Nov 2.
2
A risk-benefit assessment of growth hormone use in children.儿童使用生长激素的风险效益评估。
Drug Saf. 1997 Nov;17(5):303-16. doi: 10.2165/00002018-199717050-00003.
3
Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group.
生长激素缺乏症早期治疗患者的追赶生长。荷兰生长激素工作组。
Arch Dis Child. 1995 May;72(5):427-31. doi: 10.1136/adc.72.5.427.
4
Final height and predicted height in boys with untreated constitutional growth delay.未治疗的体质性生长延迟男孩的最终身高和预测身高。
Eur J Pediatr. 1995 Aug;154(8):627-32. doi: 10.1007/BF02079065.
5
When are we diagnosing growth hormone deficiency?我们何时诊断生长激素缺乏症？
Arch Dis Child. 1986 Feb;61(2):110-2. doi: 10.1136/adc.61.2.110.
6
Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.给药剂量和频率对生长激素治疗效果的影响
Arch Dis Child. 1988 May;63(5):491-4. doi: 10.1136/adc.63.5.491.
7
Growth hormone therapy in Canada: end of one era and beginning of another.加拿大的生长激素疗法：一个时代的结束与另一个时代的开始。
CMAJ. 1986 Aug 15;135(4):297-301.
8
The Northern Ireland experience of growth hormone therapy for short stature.北爱尔兰生长激素治疗身材矮小的经验。
Ulster Med J. 1989 Oct;58(2):153-60.
9
Optimization of growth hormone therapy in growth hormone deficient children.
Indian J Pediatr. 1991 Sep-Oct;58 Suppl 1:17-21. doi: 10.1007/BF02750979.